Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel
· Delayed Price · Currency is ILS · Price in ILA 777.80
-3.20 (-0.41%)
Jun 12, 2025, 5:24 PM IDT
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of 317.53 million as of June 12, 2025. Its market cap has decreased by -8.85% in one year.
Market Cap
317.53M
Enterprise Value
-140.00M
Revenue
7.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
766.90
Market Cap Chart
Since March 19, 2004, Oramed Pharmaceuticals's market cap has increased from 2.37M to 317.53M, an increase of 13,290.25%. That is a compound annual growth rate of 25.93%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 71.37B |
| Danel (Adir Yeoshua) | 2.48B |
| Kamada | 1.36B |
| Bait Bakfar | 1.10B |
| SofWave Medical | 744.90M |
| BrainsWay | 718.00M |
| Novolog (Pharm-Up 1966) | 714.16M |
| Ilex Medical | 691.87M |